Nizatadine

Author:Prof. Dr. med. Peter Altmeyer

All authors of this article

Last updated on: 29.10.2020

Dieser Artikel auf Deutsch

Requires free registration (medical professionals only)

Please login to access all articles, images, and functions.

Our content is available exclusively to medical professionals. If you have already registered, please login. If you haven't, you can register for free (medical professionals only).


Requires free registration (medical professionals only)

Please complete your registration to access all articles and images.

To gain access, you must complete your registration. You either haven't confirmed your e-mail address or we still need proof that you are a member of the medical profession.

Finish your registration now

DefinitionThis section has been translated automatically.

IndicationThis section has been translated automatically.

Diseases in the upper gastrointestinal tract where a reduction in gastric acid secretion is indicated, such as duodenal ulcers, benign gastric ulcers. Also for the prevention of recurrence of duodenal ulcers.

Pregnancy/nursing periodThis section has been translated automatically.

Contraindicated during pregnancy and lactation.

Dosage and method of useThis section has been translated automatically.

  • 1 time per day in the evening 1 Kps. p.o. For mite Kps.: 1 time per day 2 Kps. (in the evening) or 2 times/day (morning and evening) 1 Kps. p.o.
  • ulcer recurrence prophylaxis: 1 cps. once/day in the evening 1 cps. p.o.
  • Patients with severe renal insufficiency (creatinine clearance less than 40 ml/min or serum creatinine concentration more than 2.5 mg/100 ml) and patients over 75 years of age with duodenal/ventricular ulcers: 1 cps once a day in the evening and 1 cps every 2 days if creatinine clearance is less than 20 ml/min.

Undesirable effectsThis section has been translated automatically.

  • Occasionally: drowsiness, headache, dizziness, asthenia, chest pain, myalgia, insomnia, rhinitis, pharyngitis, cough, itching.
  • Rarely: hypersensitivity reactions (e.g. urticaria, exanthema, edematous swelling, angioedema of the lips or tongue, laryngeal edema, bronchospasm, eosinophilia), exfoliative dermatitis, sweating, anemia.

InteractionsThis section has been translated automatically.

With simultaneous administration of very high doses of acetylsalicylic acid, the ASA level is increased.

Notice! Urobilogen tests with Multistix can be false positive!

ContraindicationThis section has been translated automatically.

Pregnancy/nursing. Hypersensitivity to H2-receptor antagonists, malignant gastric ulcers, severe renal insufficiency. Caution in patients with bradycardic arrhythmias, as further slowing of the heart rhythm may occur.

Notice!

Do not use in children (insufficient data available)!

PreparationsThis section has been translated automatically.

Nizax Lilly, Nizax Lilly mite

Authors

Last updated on: 29.10.2020